Magnetic Resonance Q Mapping Reveals a Decrease in Microvessel Density in the arcAβ Mouse Model of Cerebral Amyloidosis

Alterations in density and morphology of the cerebral microvasculature have been reported to occur in Alzheimer's disease patients and animal models of the disease. In this study we compared magnetic resonance imaging (MRI) techniques for their utility to detect age-dependent changes of the cerebral vasculature in the arcAβ mouse model of cerebral amyloidosis. Dynamic susceptibility contrast (DSC)-MRI was performed by tracking the passage of a superparamagnetic iron oxide nanoparticle in the brain with dynamic gradient echo planar imaging (EPI). From this measurements relative cerebral blood volume [rCBV(DSC)] and relative cerebral blood flow (rCBF) were estimated. For the same animal maps of the relaxation shift index Q were computed from high resolution gradient echo and spin echo data that were acquired before and after superparamagnetic iron oxide (SPIO) nanoparticle injection. Q-values were used to derive estimates of microvessel density. The change in the relaxation rates ΔR2* obtained from pre- and post-contrast gradient echo data was used for the alternative determination of rCBV [rCBV(ΔR2*)]. Linear mixed effects modeling found no significant association between rCBV(DSC), rCBV(ΔR2*), rCBF, and Q with genotype in 13-month old mice [compared to age-matched non-transgenic littermates (NTLs)] for any of the evaluated brain regions. In 24-month old mice there was a significant association for rCBV(DSC) with genotype in the cerebral cortex, and for rCBV(ΔR2*) in the cerebral cortex and cerebellum. For rCBF there was a significant association in the cerebellum but not in other brain regions. Q-values in the olfactory bulb, cerebral cortex, striatum, hippocampus, and cerebellum in 24-month old mice were significantly associated with genotype. In those regions Q-values were reduced between 11 and 26% in arcAβ mice compared to age-matched NTLs. Vessel staining with CD31 immunohistochemistry confirmed a reduction of microvessel density in the old arcAβ mice. We further demonstrated a region-specific association between parenchymal and vascular deposition of β-amyloid and decreased vascular density, without a correlation with the amount of Aβ deposition. We found that Q mapping was more suitable than the hemodynamic read-outs to detect amyloid-related degeneration of the cerebral microvasculature.

[1]  D. Ingram,et al.  Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease , 2005, Brain Research Bulletin.

[2]  M. Staufenbiel,et al.  Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive Aβ Immunotherapy , 2011, The Journal of Neuroscience.

[3]  C. Rampon,et al.  Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease , 2011, Neurobiology of Aging.

[4]  Mathias Hoehn,et al.  In-Vivo Visualization of Tumor Microvessel Density and Response to Anti-Angiogenic Treatment by High Resolution MRI in Mice , 2011, PloS one.

[5]  C. Cotman,et al.  Pathogenic amyloid beta-protein induces apoptosis in cultured human cerebrovascular smooth muscle cells. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[6]  B. Hyman,et al.  Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .

[7]  D Le Bihan,et al.  Contribution of Sinerem® used as blood‐pool contrast agent: Detection of cerebral blood volume changes during apnea in the rabbit , 1996, Magnetic resonance in medicine.

[8]  M. Verbeek,et al.  Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein , 1997 .

[9]  P. Dederen,et al.  Microvascular cerebral blood volume changes in aging APPswe/PS1dE9 AD mouse model: a voxel-wise approach , 2012, Brain Structure and Function.

[10]  J. Reichenbach,et al.  Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in the Arcabeta Mouse Model of Cerebral Amyloidosis , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  P. Hof,et al.  Brain Microvascular Changes in Alzheimer's Disease and Other Dementias a , 1997, Annals of the New York Academy of Sciences.

[12]  Thomas Krucker,et al.  Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease , 2008, Proceedings of the National Academy of Sciences.

[13]  Dietmar Rudolf Thal,et al.  Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances , 2009, Neurobiology of Aging.

[14]  Hiroshi Matsuda,et al.  The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.

[15]  Toshio Moritani,et al.  Toward fully automated processing of dynamic susceptibility contrast perfusion MRI for acute ischemic cerebral stroke , 2010, Comput. Methods Programs Biomed..

[16]  M. Dhenain,et al.  Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease , 2012, Neurobiology of Aging.

[17]  Arne Møller,et al.  The capillary dysfunction hypothesis of Alzheimer's disease , 2013, Neurobiology of Aging.

[18]  Haiying Tang,et al.  Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice , 2004, Neuroscience Letters.

[19]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[20]  Roger M. Nitsch,et al.  Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice , 2007, Neurobiology of Aging.

[21]  François Hébert,et al.  Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.

[22]  A P Pathak,et al.  Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.

[23]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[24]  C. Cotman,et al.  Pathogenic amyloid β-protein induces apoptosis in cultured human cerebrovascular smooth muscle cells , 1999 .

[25]  Thomas Krucker,et al.  Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease , 2003, The Journal of Neuroscience.

[26]  R. Nitsch,et al.  Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation , 2012, Translational Psychiatry.

[27]  M. Scheunemann,et al.  Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice , 2006, International Journal of Developmental Neuroscience.

[28]  A P Pathak,et al.  MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.

[29]  R. Nitsch,et al.  Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. , 2007, Neurobiology of aging.

[30]  V. Kiselev,et al.  The Potential of Microvessel Density in Prediction of Infarct Growth: A Two-Month Experimental Study in Vessel Size Imaging , 2012, Cerebrovascular Diseases.

[31]  Markus Rudin,et al.  Contrast-Enhanced Magnetic Resonance Microangiography Reveals Remodeling of the Cerebral Microvasculature in Transgenic ArcAβ Mice , 2012, The Journal of Neuroscience.

[32]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[33]  Joanna M. Wardlaw,et al.  Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis , 2009, Neurobiology of Aging.

[34]  F. Metzger,et al.  Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: Comprehensive phenotyping of vascular and tissular parameters by MRI , 2009, Magnetic resonance in medicine.

[35]  Peter Brunecker,et al.  Vessel Size Imaging Reveals Pathological Changes of Microvessel Density and Size in Acute Ischemia , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  Oscar L Lopez,et al.  The growing burden of Alzheimer's disease. , 2011, The American journal of managed care.

[37]  Leif Østergaard,et al.  Principles of cerebral perfusion imaging by bolus tracking , 2005, Journal of magnetic resonance imaging : JMRI.

[38]  Aileen Schroeter,et al.  Early Alterations in Functional Connectivity and White Matter Structure in a Transgenic Mouse Model of Cerebral Amyloidosis , 2014, The Journal of Neuroscience.

[39]  Marc Dhenain,et al.  Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer’s disease , 2010, Magnetic Resonance Materials in Physics, Biology and Medicine.

[40]  L. Fratiglioni,et al.  Dementia prevention: current epidemiological evidence and future perspective , 2012, Alzheimer's Research & Therapy.

[41]  E. Meyer,et al.  Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice , 2011, Acta Neuropathologica.

[42]  J. C. de la Torre Impaired brain microcirculation may trigger Alzheimer's disease. , 1994, Neuroscience and biobehavioral reviews.

[43]  Wiesje M van der Flier,et al.  Brain microbleeds and Alzheimer's disease: innocent observation or key player? , 2011, Brain : a journal of neurology.

[44]  P. Grammas,et al.  Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[45]  Mark A. van Buchem,et al.  Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6T , 2012, NeuroImage.

[46]  B. Hyman,et al.  Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. , 1995, Annals of neurology.

[47]  M. Mullan,et al.  β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.

[48]  M. A. Bell,et al.  The Correlation of Vascular Capacity with the Parenchymal Lesions of Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[49]  R. Chandra,et al.  MR imaging of microvasculature , 2000, Magnetic resonance in medicine.

[50]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[51]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[52]  B. D. Ward,et al.  Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. , 2004, AJNR. American journal of neuroradiology.

[53]  G. Hellermann,et al.  Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. , 2001, Neurological research.

[54]  M. Mullan,et al.  beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.

[55]  C. Cordonnier Brain microbleeds , 2010, Practical Neurology.

[56]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[57]  L H Cheong,et al.  An automatic approach for estimating bolus arrival time in dynamic contrast MRI using piecewise continuous regression models. , 2003, Physics in medicine and biology.

[58]  M. Verbeek,et al.  Rapid degeneration of cultured human brain pericytes by amyloid beta protein. , 1997, Journal of neurochemistry.

[59]  M. Rudin,et al.  Imaging of cerebrovascular pathology in animal models of Alzheimer's disease , 2014, Front. Aging Neurosci..

[60]  Samuel Valable,et al.  In vivo imaging of vessel diameter, size, and density: A comparative study between MRI and histology , 2013, Magnetic resonance in medicine.

[61]  L. Østergaard,et al.  Comparison of gradient‐ and spin‐echo imaging: CBF, CBV, and MTT measurements by bolus tracking , 2000, Journal of magnetic resonance imaging : JMRI.

[62]  G. Hellermann,et al.  Physiological levels of β-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production , 2001 .

[63]  Haiying Tang,et al.  High‐resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q , 2004, NMR in biomedicine.

[64]  P. Carvey,et al.  Evidence of angiogenic vessels in Alzheimer’s disease , 2009, Journal of Neural Transmission.

[65]  Robia G. Pautler,et al.  Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease , 2010, PloS one.

[66]  Joanes Grandjean,et al.  Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging , 2013, PloS one.

[67]  Kaan E. Biron,et al.  Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease , 2011, PloS one.

[68]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[69]  V. Fischer,et al.  Altered angioarchitecture in selected areas of brains with Alzheimer's disease , 2004, Acta Neuropathologica.

[70]  Aline Seuwen,et al.  Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[71]  H. Vinters Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[72]  P. Hof,et al.  Stereologic Analysis of Microvascular Morphology in the Elderly: Alzheimer Disease Pathology and Cognitive Status , 2006, Journal of neuropathology and experimental neurology.

[73]  M T Madsen,et al.  A simplified formulation of the gamma variate function , 1992 .

[74]  A. Scheibel,et al.  DENERVATION MICROANGIOPATHY IN SENILE DEMENTIA, ALZHEIMER TYPE , 1987, Alzheimer disease and associated disorders.

[75]  J. D. L. Torre Impaired brain microcirculation may trigger Alzheimer's disease , 1994, Neuroscience & Biobehavioral Reviews.

[76]  Irene Otte-Höller,et al.  Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. , 2005, The American journal of pathology.